cysteine has been researched along with Psychoses in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shizuka, K; Yoneda, H | 1 |
| Burdick, KE; DeRosse, P; Goldman, D; Hodgkinson, CA; Kane, JM; Lencz, T; Malhotra, AK | 1 |
| Sherman, AD; Waziri, R; Wilson, R | 1 |
| Badri, F; Bean, G; Howard, A; Hudson, CJ; Joffe, RT; Kennedy, JL; Lieberman, J; Macciardi, FM; Meltzer, HY; Sasaki, T; Verga, M | 1 |
| Breier, A; Buchanan, RW; Clifton, A; Goldman, D; Malhotra, AK; Ozaki, N; Pickar, D; Rooney, W | 1 |
| Bujanover, Y; Lerman-Sagie, T; Lorberboym, M; Moldavsky, M; Nissenkorn, A; Raucher, A | 1 |
| Lattuada, E; Lilli, R; Lorenzi, C; Serretti, A; Smeraldi, E | 1 |
| Avrahami, E; Lerman-Sagie, T; Lorberboym, M; Nissenkorn, A | 1 |
1 review(s) available for cysteine and Psychoses
| Article | Year |
|---|---|
[Outcome of genetic studies on atypical psychoses].
Topics: Chromosomes, Human, Pair 1; Cysteine; Genetic Predisposition to Disease; Haplotypes; Humans; Membrane Proteins; Microsatellite Repeats; Molecular Diagnostic Techniques; Mutation; Polymorphism, Genetic; Presenilin-1; Psychotic Disorders; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Serine; Taq Polymerase | 2004 |
7 other study(ies) available for cysteine and Psychoses
| Article | Year |
|---|---|
Disrupted in schizophrenia 1 genotype and positive symptoms in schizophrenia.
Topics: Cysteine; Delusions; Genetic Carrier Screening; Genetic Predisposition to Disease; Genotype; Hallucinations; Haplotypes; Homozygote; Humans; Nerve Tissue Proteins; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Serine | 2007 |
Plasma serine to cysteine ratio as a biological marker for psychosis.
Topics: Adolescent; Adult; Chromatography, Gas; Cysteine; Female; Humans; Male; Middle Aged; Psychotic Disorders; Serine; Time Factors | 1983 |
No evidence for association of dopamine D2 receptor variant (Ser311/Cys311) with major psychosis.
Topics: Adult; Age of Onset; Amino Acid Sequence; Bipolar Disorder; Cysteine; Delusions; Female; Genetic Variation; Humans; Male; Middle Aged; Psychotic Disorders; Receptors, Dopamine D2; Reference Values; Schizophrenia; Serine; White People | 1996 |
Clozapine response and the 5HT2C Cys23Ser polymorphism.
Topics: Alleles; Antipsychotic Agents; Base Sequence; Clozapine; Cysteine; DNA Primers; Female; Genetic Carrier Screening; Homozygote; Humans; Male; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Predictive Value of Tests; Psychotic Disorders; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Schizophrenia; Serine | 1996 |
Postictal psychosis in a child.
Topics: Child; Cysteine; Electroencephalography; Functional Laterality; Humans; Male; Organotechnetium Compounds; Psychotic Disorders; Radiopharmaceuticals; Status Epilepticus; Tomography, Emission-Computed | 1999 |
Dopamine receptor D2 Ser/Cys 311 variant is associated with delusion and disorganization symptomatology in major psychoses.
Topics: Adult; Amino Acid Substitution; Bipolar Disorder; Cysteine; Depressive Disorder; Female; Genetic Variation; Humans; Male; Middle Aged; Psychotic Disorders; Receptors, Dopamine D2; Reference Values; Schizophrenia; Schizophrenia, Paranoid; Serine | 2000 |
Technetium-99m-ethyl cysteinate dimer brain perfusion loss in pediatric postictal psychosis.
Topics: Anticonvulsants; Brain; Child; Cysteine; Diagnosis, Differential; Humans; Magnetic Resonance Imaging; Male; Neurologic Examination; Organotechnetium Compounds; Psychotic Disorders; Radiopharmaceuticals; Status Epilepticus; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2000 |